The 2026 Workshop Program is under development.
Program is subject to change.
BETWEEN JULY 10 – 24
Pre-Workshop Protocol Development Group Introduction Session
FRIDAY, JULY 24
Workshop Pretest available, to be completed by 5 p.m. on Sunday, July 26
SUNDAY, JULY 26
Shuttles from Denver International Airport
11 am-1:30 pm / 12:30-3 pm / 1:30-4 pm
Registration
1-7 pm
Faculty Meeting
4:45-5:45 pm
Welcome/Overview
6-6:30 pm
- Tari King, Emory University and Winship Cancer Institute, Atlanta, Georgia
- Wendy B. London, Dana-Farber Cancer Institute and Boston Children’s Hospital, Boston, Massachusetts
- Timothy A. Yap, The University of Texas Anderson Cancer Center, Houston, Texas
Lecture Session 1
6:30-7 pm
- Answering Important Questions: From Hypothesis to Analysis
Wendy B. London, Dana-Farber Cancer Institute and Boston Children’s Hospital, Boston, Massachusetts
Protocol Development Group Session 1 / Working Dinner
7-9 pm
MONDAY, JULY 27
Breakfast
7-8 am
Lecture Session 2
8-9:50 am
- Phase I Trial Designs and Questions
Shing Lee, Columbia University, New York, New York
Patricia M. LoRusso, Yale University, New Haven, Connecticut - Phase II Trial Designs, Questions, and Objectives
Bora Lim, The University of Texas MD Anderson Cancer Center, Houston, Texas
Mary W. Redman, Fred Hutchinson Cancer Center, Seattle, Washington - Questions / Panel Discussion
- TAKE NOTE: How will this session be applied to your protocol
Break
9:50-10 am
Lecture Session 3
10-11:40 am
- Project Optimus: Reforming Dose Optimization and Dose Selection
Timothy A. Yap, The University of Texas Anderson Cancer Center, Houston, Texas - Combination and Multimodality Trials
-Surgery
Amir A. Jazaeri, The University of Texas MD Anderson Cancer Center, Houston, Texas
-Radiation
Ramesh Rengan, University of Washington School of Medicine, Seattle, Washington
-Systemic Therapy
Rachna T. Shroff, University of Arizona Cancer Center, Tucson, Arizona - Questions / Panel Discussion
- TAKE NOTE: How will this session be applied to your protocol
Group Writing Session 1
11:40 am – 12:15 pm
Protocol Development Group Session 2 / Working Lunch
12:15-2:30 pm
Office Hours 1: Biostatistician Faculty Only (Prescheduled Appointments, with PDG Biostatistician Faculty)
2:45-4:45 pm
Independent Study / Protocol Work
4:45-6:30 pm
ASSIGNMENT DUE: PROTOCOL TEMPLATE
6:30 pm
Group Dinner / Icebreaker Event
6:30-8:30 pm
TUESDAY, JULY 28
Breakfast
7-8 am
Lecture Session 4
8-9:45 am
- Incorporation of Biological Correlative Studies into Early Clinical Trials
Jordi Rodon Ahnert, The University of Texas MD Anderson Cancer Center, Houston, Texas - Feasibility and Reproducibility in Biomarker Studies
Kurt A. Schalper, Yale University, New Haven, Connecticut - Statistical Aspects of Correlative Studies
Arzu Onar-Thomas, St. Jude Children’s Research Hospital, Memphis, Tennessee - Questions / Panel Discussion
- TAKE NOTE: How will this session be applied to your protocol
Break
9:45-10 am
Lecture Session 5
10-11:15 am
- Imaging in the Era of Targeted Therapy and Immunotherapy
Anna Spreafico, University Health Network Princess Margaret Cancer Centre, Toronto, ON, Canada - Special Considerations in the Design of Immunotherapy Studies
Elizabeth I. Buchbinder, Mass General Cancer Center, Boston, Massachusetts - Questions / Panel Discussion
- TAKE NOTE: How will this session be applied to your protocol
Group Writing Session 2
11:15 am-12 pm
Lunch
12-1 pm
Protocol Development Group Session 3
1-4 pm
Office Hours 2: Statistical Design and Protocol Related Questions
4:15-6:30 pm
Grab and Go Dinner
6:30-8 pm
ASSIGNMENT DUE: STATISTICAL DESIGN
8 pm
WEDNESDAY, JULY 29
Breakfast
7-8 am
Small Group Discussion Sessions 1-3
8-9 am
- Elements of Artificial Intelligence
Carole L. Baas, Physical Sciences in Oncology Network, Southlake, Texas
Adam P. Dicker, Thomas Jefferson University, Philadelphia, Pennsylvania
Robert G. Maki, Memorial Sloan Kettering Cancer Center, New York, New York - Symptom Management, Patient Reported Outcomes, and Quality of Life
Jill Feldman, EGFR Resisters, Evanston, Illinois
Michelle Nuno, University of Southern California, Los Angeles, California
Ann H. Partridge, Dana-Farber Cancer Institute, Boston, Massachusetts - Laboratory Correlates, ctDNA, and Liquid Biopsy
Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, New York
Chen Hu, Johns Hopkins University School of Medicine, Baltimore, Maryland
Paul E. Oberstein, NYU Langone Health Permutter Cancer Center, New York, New York
Kurt A. Schalper, Yale University, New Haven, Connecticut
Patricia Spears, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Timothy A. Yap, The University of Texas MD Anderson Cancer Center, Houston, Texas
Break
9-9:15 am
Small Group Discussion Sessions 4-6
9:15-10:15 am
- Repeated from above
Break / Group Photo
10:15-10:45 am
Protocol Development Group Session 4
10:45 am-1:15 pm
Lunch
1:15 pm-2:15 pm
Office Hours 3: Informed Consent and Protocol Questions
2:15 pm-4:30 pm
Independent Study / Protocol Work
2:15-7 pm
Grab and Go Dinner
5-6:30 pm
ASSIGNMENT DUE: INFORMED CONSENT DRAFTS
7 pm
THURSDAY, JULY 30
Breakfast
7-8 am
Lecture Session 6
8-10:15 am
- You’re in Charge: Investigator Responsibilities
John P. Leonard, NYU Langone, New York, New York - How to Pay for Your Trial
Maha H. Hussain, Northwestern University Feinberg School of Medicine, Chicago, Illinois - Successful Grantsmanship
John C. Byrd, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania - Data Collection: It’s All in the Data
Lindsay Renfro, University of Southern California, Los Angeles, California - Reporting and Presenting Results
Tari King, Emory University and Winship Cancer Institute, Atlanta Georgia
Emily Zabor, Cleveland Clinic, Cleveland, Ohio - Questions / Panel Discussion
- TAKE NOTE: How will this session be applied to your protocol
Break
10:15-10:30 am
Lecture Session 7
10:30-11:30 am
- Everything You Need to Know About Clinical Trial Ethics and Informed Consent
Tracy T. Batchelor, Mass General Brigham, Boston, Massachusetts
Julia Maués, GRASP Cancer, Baltimore, Maryland
Robert G. Maki, Memorial Sloan Kettering Cancer Center, New York, New York
Elizabeth R. Plimack, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Patricia Spears, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Post-Test Available
11:30 am-7 pm
Protocol Development Group Session 5 / Working Lunch
11:45 am-2:45 pm
Office Hours 4: Career and Professional Development
3-5 pm
Independent Study / Protocol Work
3-7 pm
ASSIGNMENT DUE: FINAL PROTOCOLS, INFORMED CONSENT FORMS, and ALL WORKSHOP EVALUATIONS
7 pm
Closing Reception, Banquet, and Awards Ceremony
7-9 pm
FRIDAY, JULY 31
Grab and Go Breakfast
5-8 am
Shuttles to Denver International Airport
5:30-8 am / 6:30-9 am / 7:30-10 am